Effects of essential medicines on cardiovascular products available for the market in Thailand

National List of Essential Medicines (NLEM) is an important policy on drugs, which also covers the drug availability. However, the link between the list and the availability of medicine products for the market is not clear. The objectives of this study were to examine the effects of essential medici...

Full description

Saved in:
Bibliographic Details
Main Authors: Siriporn Burapadaja, Naohito Kawasaki, Suporn Charumanee, Fumihiko Ogata
Format: Journal
Published: 2018
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34848854480&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/61240
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-61240
record_format dspace
spelling th-cmuir.6653943832-612402018-09-10T04:07:19Z Effects of essential medicines on cardiovascular products available for the market in Thailand Siriporn Burapadaja Naohito Kawasaki Suporn Charumanee Fumihiko Ogata Medicine National List of Essential Medicines (NLEM) is an important policy on drugs, which also covers the drug availability. However, the link between the list and the availability of medicine products for the market is not clear. The objectives of this study were to examine the effects of essential medicines (EM) on the patterns and values of cardiovascular products available for the market in Thailand. Issues investigated were proportions of products, expansions of generic names, involvement of producers and relation between the numbers of EM generic names and production values of products. Data sources were NLEM, Thailand Index of Medical Specialities and drug statistics by Food and Drug Administration (FDA). Results revealed the availability of 623 products from 127 generic names. On average, EM products showed significantly greater proportions and EM generic names demonstrated larger expansions than non-EM. Domestic producers contributed to List A products by a significantly higher percentage than foreign, but only foreign producers introduced List D products. There was a positive and significant relation between the numbers of EM generic names and the production values of products. In conclusion, it was clear that EM had effects on the patterns and the values of cardiovascular products available for the market. Subsequent prices and expenditure due to the patterns and values of product availability could be low or high. These findings could be advantageous in using essential medicines as a means to avoid the negative consequences by addressing the significance of its kinds and numbers when selecting it in the list. © 2007. 2018-09-10T04:07:19Z 2018-09-10T04:07:19Z 2007-11-01 Journal 01688510 2-s2.0-34848854480 10.1016/j.healthpol.2007.01.012 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34848854480&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/61240
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
topic Medicine
spellingShingle Medicine
Siriporn Burapadaja
Naohito Kawasaki
Suporn Charumanee
Fumihiko Ogata
Effects of essential medicines on cardiovascular products available for the market in Thailand
description National List of Essential Medicines (NLEM) is an important policy on drugs, which also covers the drug availability. However, the link between the list and the availability of medicine products for the market is not clear. The objectives of this study were to examine the effects of essential medicines (EM) on the patterns and values of cardiovascular products available for the market in Thailand. Issues investigated were proportions of products, expansions of generic names, involvement of producers and relation between the numbers of EM generic names and production values of products. Data sources were NLEM, Thailand Index of Medical Specialities and drug statistics by Food and Drug Administration (FDA). Results revealed the availability of 623 products from 127 generic names. On average, EM products showed significantly greater proportions and EM generic names demonstrated larger expansions than non-EM. Domestic producers contributed to List A products by a significantly higher percentage than foreign, but only foreign producers introduced List D products. There was a positive and significant relation between the numbers of EM generic names and the production values of products. In conclusion, it was clear that EM had effects on the patterns and the values of cardiovascular products available for the market. Subsequent prices and expenditure due to the patterns and values of product availability could be low or high. These findings could be advantageous in using essential medicines as a means to avoid the negative consequences by addressing the significance of its kinds and numbers when selecting it in the list. © 2007.
format Journal
author Siriporn Burapadaja
Naohito Kawasaki
Suporn Charumanee
Fumihiko Ogata
author_facet Siriporn Burapadaja
Naohito Kawasaki
Suporn Charumanee
Fumihiko Ogata
author_sort Siriporn Burapadaja
title Effects of essential medicines on cardiovascular products available for the market in Thailand
title_short Effects of essential medicines on cardiovascular products available for the market in Thailand
title_full Effects of essential medicines on cardiovascular products available for the market in Thailand
title_fullStr Effects of essential medicines on cardiovascular products available for the market in Thailand
title_full_unstemmed Effects of essential medicines on cardiovascular products available for the market in Thailand
title_sort effects of essential medicines on cardiovascular products available for the market in thailand
publishDate 2018
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=34848854480&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/61240
_version_ 1681425583802679296